Treatment of severe active systemic lupus erythematosus by PMC therapy combined Langchuang Fuzheng J

• 作 者: 宋欣伟
• 机 构: Dept Rheumat,Zhejiang TCM Hosp,
• 出 处: China Medical Abstracts(Internal Medicine)
• 发表日期: 2013年04期
• 关键词: erythematosus integrative glucocorticoid capsule assigned withdrawal Rehmannia s

Objective To evaluate the efficacy and safety of PMC therapy (Prednisone,Methotrexate,Chloroquine) combined Langchuang Fuzheng Jiedu Capsule (LFJC) ,thus choosing a better therapy of integrative medicine for SLE in the period of glucocorticoid use.Methods Sixty active SLE patients were randomly assigned to two groups,the control group and the treatment group.Those in the control group received PMC therapy (As for Prednisone,it was given at the daily dose of 1 mg/kg till 2weeks after the condition being stable or after 8 weeks of

Objective To evaluate the efficacy and safety of PMC therapy (Prednisone, Methotrexate, Chloroquine) combined Langchuang Fuzheng Jiedu Capsule (LFJC), thus choosing a better therapy of integrative medicine for SLE in the period of glucocorticoid use. Methods Sixty active SLE patients were randomly selected assigned to two groups, the control group and the treatment group.Those in the control group received PMC therapy (As for Prednisone, it was given at the daily dose of 1 mg / kg till 2 weeks later the condition being stable or after 8 weeks of